Table Of Content

ELSEVIER Author index \DHD I AFFERCWA TIVE DISORDERS Subject index Adolescent; Bipx Bipolar disorder; Dr lies 58, Adolescent; Brief episodes; B 58, Dr Affective disorders; A Brofaromine; P! t 58, Iryy ne 58, Affective disorders; S Cardiovascular disease; Par 58, Sieep pal 58, I Age at onset: M Child; Asi } 58, Aggregate rates; | Childhood anxiety: ADHD): Comorbidit Agoraphobia; P Antidepressant drug; EC! Child-related stress; P t} Anxiet Il) pt Antioxidant; D Chinese; Bip S Anxiety; Cholesterol; P Anxiety; A 58. Citalopram infusion; ( 58, Association studies; 58, ¢ Citalopram tablet; ‘ 58, Asthma; A D 58, Clinical subtypes; M I Attempted suicide; R LD Community study; De; Attention deficit hyperactivity disorder (ADHD); Comorbidity; Au ADHD bidity; P lisorder 58, 99 qj dhood nxiet P ‘ Bipolar affective disorder; WS/ Course; Dystl D Bipolar affective disorder; A Cytokine; Moclob« Dr px IQ 58, Cytokines; Depr Bipolar affective disorder; Cl Oxidat S pore 58, Depression; WS/ Bipolar depression; Soc Bipolar disorder; Dopai " eptors; DRD2: DRD3 Depression; SSRIs Depression Fatty acids; Ih pression, General medicine: 58, I pression Health-related quality of life; D Depression ( 58, 58 High recurrence: Depression Ik pression S-HT2A receptor gene; > s 58, I pression; 5-Hydroxytryptamine; P S8 58. Depression; Depression; Sk. Immune; Dissociative identity disorder; us Immunity: Dopamine receptors; Double depression; 58 Japanese women; M EPDS 58, DRD2 Linkage: DRDS3 Lithium response; Drug response Long-term treatment; Drug-discontinuation; Lymphocyte proliferation; Dyadic relationship: 58 58, Major depression; D Dysthy mia; Mania; S Dysthymic disorder; 58, Manic-depressive illness; A | k 58, Early onset; M sR. Marital support; A 58. ECT Maternal mental health; P Electroconvulsive therapy; Der P ( EPDS; M Maternity blues: P Ethnicity; Meta-analysis; SSRI ( False memory; A Moclobemide; ( Moclobemide; P! Familial risk; Mi } Ss Iryptami 58. Multiple personality disorder: Relapse; j rv: D Negative symptoms; D Risk; D 58, Schizophrenia; | Neurovegetative features: 58, | Self-esteem; S Older people; D Serotonin; C! Outpatient; D > pore 38, ( Severe depression; ( Onxidative stress; il ts 58, Singapore; ( Panic attacks: A HT2A } Sleep panic; P Panic attack; P S 58, Social support; S Panic disorder: A ( Spouse; All 58, Panic disorder; ( S 58, SSRIs: Parental strain: P SSRIs; | PDL: Stressful life events: Doul lepr ion 58, Phase Hl trial; ¢ Sx. Survival analysis: Ma bivpc I Phenelzine; 58, Systematic review; SSR Positive symptoms; 58. PCAs: SSRIs: Dep Postnatal depression; 58, INF-a; M lrinucleotide repeats; Prevention; R Psychiatric epidemiology; M I'ryptamine; ) Pp Psychotic features; Bip " Dy Tyrosine hydroxylase: | k Bip rd Quality of life: R Recovered memory: WSF Igene mutation; D Recurrence; D